In the case of ovarian cancer, research indicates that Mucin‐16 (MUC16) and Mesothelin (MSLN) are significant tumour antigens, presented respectively by human leukocyte antigen‐I and human leukocyte antigen‐II molecules.40 This evidence concerns the gene MUC16 and ovarian cancer.